Non classé


Figures – Biotechnologies & Health in Japan

Jan bioindustry
Partager sur facebook
Partager sur twitter
Partager sur linkedin
Partager sur google
Partager sur reddit
Partager sur tumblr
Partager sur pinterest

Japan Gross Domestic Product 2016 was about $4.9 trillions (7.97 % of the world economy).

–Japan has been ranked 16th by the Global Innovation Index 2016:

• 9th for the proportion of researchers in general population: 5.4 for 1.000 inhabitants

• 15th for academia/industry cooperation

• 3rd for its R&D intensity : 3.59% of its GDP as of june 2016

• 9th for clusters development

•1st on innovation quality –

–The 5th Science & Technology Basic Plan (2016-2020) plan on a combined private/public investment of 4% GDP in R&D, 1% coming from the government (about ¥26 trillions).

–According to the JBA, there were 591 bio-venture companies in 2014, about 150 of them being small firms (under 50 employees) according to the OECD.

–Medical devices and pharmaceuticals market: Japan is the second market worldwide with 10% of the market share.

–The biotechnology industry was valued at ¥3 trillion in 2015.

–Expected bioindustry social contribution in 2030 : market size ¥40 trillions, GDP ¥20 trillions, 80 millions jobs.

–Japanese regenerative medicine market prevision for 2030 :  ¥1 trillion.

–The Japanese population was about 127 million in 2015 and is expected to fall to less than 85 million by 2050.

–People over 65 years old are approaching 30% of the population and are expected to exceed 40% by 2050.

100 ¥ = 0,89 $